Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuno Vau

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cancers|January 6, 2021
Immune Checkpoint Inhibitors for the Treatment of Bladder CancerAntonio Lopez-Beltran, Alessia Cimadamore, Ana Blanca, et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|October 18, 2022
A case of lymphocytic myocarditis in a patient treated with an immune checkpoint inhibitor, a recent class of chemotherapy agentsTatiana Duarte, Cátia Costa, Sara Gonçalves, et al.
Human Pathology|August 24, 2019
Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor noduleNuno Vau, Vanessa Henriques, Liang Cheng, et al.
Cancers|February 13, 2026
FGFR Testing in Metastatic Urothelial Carcinoma-Who, When, and How to TestAndré Mansinho, José Carlos Machado, Cátia Faustino, et al.
Virchows Archiv : an International Journal of Pathology|January 4, 2023
Pleomorphic giant cell carcinoma of the prostate: clinicopathologic analysis and oncological outcomesAndreia Bilé-Silva, Antonio Lopez-Beltran, Henrique Rasteiro, et al.
Virchows Archiv : an International Journal of Pathology|February 18, 2018
Digital versus light microscopy assessment of surgical margin status after radical prostatectomyMetka Volavšek, Ana Blanca, Rodolfo Montironi, et al.
Virchows Archiv : an International Journal of Pathology|October 8, 2019
Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samplesMetka Volavšek, Vanessa Henriques, Ana Blanca, et al.
Expert Opinion on Biological Therapy|April 10, 2023
Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forwardAndreia Bilé-Silva, Antonio Lopez-Beltran, Ana Blanca, et al.
Expert Opinion on Therapeutic Targets|March 11, 2017
Tp53 and its potential therapeutic role as a target in bladder cancerChiara Ciccarese, Francesco Massari, Ana Blanca, et al.
Current Drug Targets|February 5, 2016
Emerging Immunotargets in Bladder CancerFrancesco Massari, Chiara Ciccarese, Nuno Vau, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cancers|January 6, 2021
Immune Checkpoint Inhibitors for the Treatment of Bladder CancerAntonio Lopez-Beltran, Alessia Cimadamore, Ana Blanca, et al.
Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology|October 18, 2022
A case of lymphocytic myocarditis in a patient treated with an immune checkpoint inhibitor, a recent class of chemotherapy agentsTatiana Duarte, Cátia Costa, Sara Gonçalves, et al.
Human Pathology|August 24, 2019
Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor noduleNuno Vau, Vanessa Henriques, Liang Cheng, et al.
Cancers|February 13, 2026
FGFR Testing in Metastatic Urothelial Carcinoma-Who, When, and How to TestAndré Mansinho, José Carlos Machado, Cátia Faustino, et al.
Virchows Archiv : an International Journal of Pathology|January 4, 2023
Pleomorphic giant cell carcinoma of the prostate: clinicopathologic analysis and oncological outcomesAndreia Bilé-Silva, Antonio Lopez-Beltran, Henrique Rasteiro, et al.
Virchows Archiv : an International Journal of Pathology|February 18, 2018
Digital versus light microscopy assessment of surgical margin status after radical prostatectomyMetka Volavšek, Ana Blanca, Rodolfo Montironi, et al.
Virchows Archiv : an International Journal of Pathology|October 8, 2019
Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samplesMetka Volavšek, Vanessa Henriques, Ana Blanca, et al.
Expert Opinion on Biological Therapy|April 10, 2023
Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forwardAndreia Bilé-Silva, Antonio Lopez-Beltran, Ana Blanca, et al.
Expert Opinion on Therapeutic Targets|March 11, 2017
Tp53 and its potential therapeutic role as a target in bladder cancerChiara Ciccarese, Francesco Massari, Ana Blanca, et al.
Current Drug Targets|February 5, 2016
Emerging Immunotargets in Bladder CancerFrancesco Massari, Chiara Ciccarese, Nuno Vau, et al.
Pageof 3